Prickle-1 Negatively Regulates Wnt/β-Catenin Pathway by Promoting Dishevelled Ubiquitination/Degradation in Liver Cancer

Gastroenterology

Volumn 131, Issue 4, 2006, Pages 1218-1227

  Chan, David W ^a   Chan, Chung Yiu ^a   Yam, Judy W P ^a   Ching, Yick Pang ^a   Ng, Irene O L ^a  

^a SH Ho Foundation Research Laboratories   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PRICKLE 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

EID: 33749501476     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.07.020     Document Type: Article

References (37)

1. Cadigan K.M., and Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 11 (1997) 3286-3305
2. Brown J.D., and Moon R.T. Wnt signaling: why is everything so negative?. Curr Opin Cell Biol 10 (1998) 182-187
3. Peifer M., and Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 287 (2000) 1606-1609
4. Bienz M., and Clevers H. Linking colorectal cancer to Wnt signaling. Cell 103 (2000) 311-320
5. Polakis P. Wnt signaling and cancer. Genes Dev 14 (2000) 1837-1851
6. Lustig B., and Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129 (2003) 199-221
7. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653 (2003) 1-24
8. Wong C.M., Fan S.T., and Ng I.O. β-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 92 (2001) 136-145
9. Ishizaki Y., Ikeda S., Fujimori M., Shimizu Y., Kurihara T., Itamoto T., Kikuchi A., Okajima M., and Asahara T. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Int J Oncol 24 (2004) 1077-1083
10. Cui J., Zhou X., Liu Y., Tang Z., and Romeih M. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes. J Gastroenterol Hepatol 18 (2003) 280-287
11. Gubb D., Green C., Huen D., Coulson D., Johnson G., Tree D., Collier S., and Roote J. The balance between isoforms of the prickle LIM domain protein is critical for planar polarity in Drosophila imaginal discs. Genes Dev 13 (1999) 2315-2327
12. Tree D.R., Shulman J.M., Rousset R., Scott M.P., Gubb D., and Axelrod J.D. Prickle mediates feedback amplification to generate asymmetric planar cell polarity signaling. Cell 109 (2002) 371-381
13. Takeuchi M., Nakabayashi J., Sakaguchi T., Yamamoto T.S., Takahashi H., Takeda H., and Ueno N. The prickle-related gene in vertebrates is essential for gastrulation cell movements. Curr Biol 13 (2003) 674-679
14. Carreira-Barbosa F., Concha M.L., Takeuchi M., Ueno N., Wilson S.W., and Tada M. Prickle 1 regulates cell movements during gastrulation and neuronal migration in zebrafish. Development 130 (2003) 4037-4046
15. Veeman M.T., Slusarski D.C., Kaykas A., Louie S.H., and Moon R.T. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr Biol 13 (2003) 680-685
16. Wharton Jr. K.A. Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev Biol 253 (2003) 1-17
17. Nagahata T., Shimada T., Harada A., Nagai H., Onda M., Yokoyama S., Shiba T., Jin E., Kawanami O., and Emi M. Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers. Cancer Sci 94 (2003) 515-518
18. Okino K., Nagai H., Hatta M., Nagahata T., Yoneyama K., Ohta Y., Jin E., Kawanami O., Araki T., and Emi M. Up-regulation and overproduction of DVL-1, the human counterpart of the Drosophila dishevelled gene, in cervical squamous cell carcinoma. Oncol Rep 10 (2003) 1219-1223
19. Uematsu K., He B., You L., Xu Z., McCormick F., and Jablons D.M. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 22 (2003) 7218-7221
20. Uematsu K., Kanazawa S., You L., He B., Xu Z., Li K., Peterlin B.M., McCormick F., and Jablons D.M. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 63 (2003) 4547-4551
21. Ng I.O., Lai E.C., Fan S.T., Ng M.M., and So M.K. Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer 76 (1995) 2443-2448
22. Cadoret A., Ovejero C., Terris B., Souil E., Levy L., Lamers W.H., Kitajewski J., Kahn A., and Perret C. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 21 (2002) 8293-8301
23. Tan X., Apte U., Micsenyi A., Kotsagrelos E., Luo J.H., Ranganathan S., Monga D.K., Bell A., Michalopoulos G.K., and Monga S.P. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology 129 (2005) 285-302
24. Stambolic V., Ruel L., and Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6 (1996) 1664-1668
25. Zachariae W., and Nasmyth K. Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev 13 (1999) 2039-2058
26. Zachariae W. Destruction with a box: substrate recognition by the anaphase-promoting complex. Mol Cell 13 (2004) 2-3
27. Natsume H., Sasaki S., Kitagawa M., Kashiwabara Y., Matsushita A., Nakano K., Nishiyama K., Nagayama K., Misawa H., Masuda H., and Nakamura H. Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone. Biochem Biophys Res Commun 309 (2003) 408-413
28. Kitagawa M., Hatakeyama S., Shirane M., Matsumoto M., Ishida N., Hattori K., Nakamichi I., Kikuchi A., and Nakayama K. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J 18 (1999) 2401-2410
29. Kishida S., Yamamoto H., Hino S., Ikeda S., Kishida M., and Kikuchi A. DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol 19 (1999) 4414-4422
30. Li L., Yuan H., Xie W., Mao J., Caruso A.M., McMahon A., Sussman D.J., and Wu D. Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J Biol Chem 274 (1999) 129-134
31. Hino S., Kishida S., Michiue T., Fukui A., Sakamoto I., Takada S., Asashima M., and Kikuchi A. Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein. Mol Cell Biol 21 (2001) 330-342
32. Cromer A., Carles A., Millon R., Ganguli G., Chalmel F., Lemaire F., Young J., Dembele D., Thibault C., Muller D., Poch O., Abecassis J., and Wasylyk B. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23 (2004) 2484-2498
33. Habas R., Kato Y., and He X. Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell 107 (2001) 843-854
34. Yau T.O., Chan C.Y., Chan K.L., Lee M.F., Wong C.M., Fan S.T., and Ng I.O. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Oncogene 24 (2005) 1607-1614
35. Simons M., Gloy J., Ganner A., Bullerkotte A., Bashkurov M., Kronig C., Schermer B., Benzing T., Cabello O.A., Jenny A., Mlodzik M., Polok B., Driever W., Obara T., and Walz G. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat Genet 37 (2005) 537-543
36. Glotzer M., Murray A.W., and Kirschner M.W. Cyclin is degraded by the ubiquitin pathway. Nature 349 (1991) 132-138
37. Katoh M. WNT/PCP signaling pathway and human cancer. Oncol Rep 14 (2005) 1583-1588